Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALPRAZOLAM Cause Incorrect dose administered? 149 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 149 reports of Incorrect dose administered have been filed in association with ALPRAZOLAM (Alprazolam). This represents 0.3% of all adverse event reports for ALPRAZOLAM.

149
Reports of Incorrect dose administered with ALPRAZOLAM
0.3%
of all ALPRAZOLAM reports
5
Deaths
50
Hospitalizations

How Dangerous Is Incorrect dose administered From ALPRAZOLAM?

Of the 149 reports, 5 (3.4%) resulted in death, 50 (33.6%) required hospitalization, and 4 (2.7%) were considered life-threatening.

Is Incorrect dose administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALPRAZOLAM. However, 149 reports have been filed with the FAERS database.

What Other Side Effects Does ALPRAZOLAM Cause?

Drug abuse (8,827) Toxicity to various agents (7,157) Completed suicide (4,873) Drug ineffective (4,040) Overdose (2,967) Drug dependence (2,743) Somnolence (2,461) Intentional overdose (2,389) Death (2,317) Suicide attempt (2,313)

What Other Drugs Cause Incorrect dose administered?

TIRZEPATIDE (23,301) ADALIMUMAB (14,000) DUPILUMAB (9,907) RANITIDINE (9,337) INSULIN LISPRO (8,318) ACETAMINOPHEN (5,316) DULAGLUTIDE (5,207) SECUKINUMAB (4,524) INSULIN GLARGINE (3,070) SOMATROPIN (2,772)

Which ALPRAZOLAM Alternatives Have Lower Incorrect dose administered Risk?

ALPRAZOLAM vs ALPROSTADIL ALPRAZOLAM vs ALTEPLASE ALPRAZOLAM vs ALTERNARIA ALTERNATA ALPRAZOLAM vs ALTHIAZIDE ALPRAZOLAM vs ALTHIAZIDE\SPIRONOLACTONE

Related Pages

ALPRAZOLAM Full Profile All Incorrect dose administered Reports All Drugs Causing Incorrect dose administered ALPRAZOLAM Demographics